top of page

Frontline Treatment of CD30-Expressing Lymphomas

Tue, Aug 06

|

Seasons 52

Seattle Genetics cordially invites you to an educational program. Frontline Advancements: Clinical Data Overview of Echelon-1 and Echelon-2.

Registration is Closed
See other events
Frontline Treatment of CD30-Expressing Lymphomas
Frontline Treatment of CD30-Expressing Lymphomas

Time & Location

Aug 06, 2019, 6:00 PM

Seasons 52, 220 Boylston St, Chestnut Hill, MA 02467, USA

Guests

About The Event

To RSVP or for information regarding ADCETRIS, contact your local Seattle Genetics Account Manager, Carrie Maricic at (603) 339-3451 or via email at cmaricic@seagen.com.

FRONTLINE ADVANCEMENTS:

CLINICAL DATA OVERVIEW OF ECHELON-1 AND ECHELON-2

Join us to review data from 2 pivotal trials assessing ADCETRIS+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and ADCETRIS+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphomas (PTCL).1

Presented by Krista Tucker, APRN

Tufts University Medical School

Share This Event

BONS logo.png

Contact:

Daunielle Ricardi, President

Alissa Gentile, Treasurer

Cameron Keith, Social Media Coordinator

Email: BonsSocialMedia@gmail.com

  • Facebook
  • Instagram
  • LinkedIn
Earthen Media-4.png
bottom of page